The only significant difference in any group was seen for non-BRCA mutation carriers, where I1307K carriers were significantly more likely to be grade 2 rather than grade 1 (OR 5.0, 95% CI 1.23-21, P = 0.04) but this was only of borderline significance.
← all excerpts
The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
1
—
—